Tue, Jul 22, 2014, 3:36 AM EDT - U.S. Markets open in 5 hrs 54 mins

Recent

% | $
Click the to save as a favorite.

Ariad Pharmaceuticals Inc. Message Board

  • mgiganti74 mgiganti74 Oct 31, 2013 12:17 PM Flag

    I am new to ariad. Why was there such a big selloff in early Oct.?

    Thanks for the information.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Read the press releases. "ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) is discontinuing the Phase 3 EPIC (Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia) trial of Iclusig┬« (ponatinib) in patients with newly diagnosed chronic myeloid leukemia (CML). ARIAD and the U.S. Food and Drug Administration mutually agreed that the trial should be terminated because arterial thrombotic events were observed in patients treated with Iclusig. This decision was made in the interest of patient safety based on a recent assessment of data in the clinical trial."

    • rqtect@ymail.com rqtect Oct 31, 2013 12:27 PM Flag

      a few people with stage 4 cancer died....
      sorry to sound so cold but that happens everyday.

      FDA freaks out, Knee Jerk anyone
      stock pluments

      Now the company is going to pull it VOLINTARILY sp
      Do more of its own tests .. in two weeks to a month it will be back on the US market.

      Bottom Line Drug is safe and I am sad that so many people with stage four die everyday.
      Thank God for companies like ARIA trying to help.

 
ARIA
5.15-0.05(-0.96%)Jul 21 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.